These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 23747245)

  • 41. Pathophysiology of insulin secretion in non-insulin-dependent diabetes mellitus.
    Ward WK; Beard JC; Halter JB; Pfeifer MA; Porte D
    Diabetes Care; 1984; 7(5):491-502. PubMed ID: 6094129
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of innate immune cells in metabolism: from physiology to type 2 diabetes.
    Dalmas E
    Semin Immunopathol; 2019 Jul; 41(4):531-545. PubMed ID: 30953161
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Minireview: Emerging Concepts in Islet Macrophage Biology in Type 2 Diabetes.
    Morris DL
    Mol Endocrinol; 2015 Jul; 29(7):946-62. PubMed ID: 26001058
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alternative macrophage activation and metabolism.
    Odegaard JI; Chawla A
    Annu Rev Pathol; 2011; 6():275-97. PubMed ID: 21034223
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical aspects of islet B-cell function in non-insulin-dependent diabetes mellitus.
    Ward WK; Beard JC; Porte D
    Diabetes Metab Rev; 1986; 2(3-4):297-313. PubMed ID: 3527617
    [No Abstract]   [Full Text] [Related]  

  • 46. Expression of the kynurenine pathway enzymes in the pancreatic islet cells. Activation by cytokines and glucolipotoxicity.
    Liu JJ; Raynal S; Bailbé D; Gausseres B; Carbonne C; Autier V; Movassat J; Kergoat M; Portha B
    Biochim Biophys Acta; 2015 May; 1852(5):980-91. PubMed ID: 25675848
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Influence of Type 2 Diabetes-Associated Factors on Type 1 Diabetes.
    Redondo MJ; Evans-Molina C; Steck AK; Atkinson MA; Sosenko J
    Diabetes Care; 2019 Aug; 42(8):1357-1364. PubMed ID: 31167894
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modulation of the pancreatic islet-stress axis as a novel potential therapeutic target in diabetes mellitus.
    Ludwig B; Barthel A; Reichel A; Block NL; Ludwig S; Schally AV; Bornstein SR
    Vitam Horm; 2014; 95():195-222. PubMed ID: 24559919
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pancreatic islet inflammation in type 2 diabetes: from alpha and beta cell compensation to dysfunction.
    Ehses JA; Ellingsgaard H; Böni-Schnetzler M; Donath MY
    Arch Physiol Biochem; 2009 Oct; 115(4):240-7. PubMed ID: 19645635
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Macrophages, cytokines and beta-cell death in Type 2 diabetes.
    Ehses JA; Böni-Schnetzler M; Faulenbach M; Donath MY
    Biochem Soc Trans; 2008 Jun; 36(Pt 3):340-2. PubMed ID: 18481953
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cytokine production by islets in health and diabetes: cellular origin, regulation and function.
    Donath MY; Böni-Schnetzler M; Ellingsgaard H; Halban PA; Ehses JA
    Trends Endocrinol Metab; 2010 May; 21(5):261-7. PubMed ID: 20096598
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Irreversible inhibition of metabolic function and islet destruction after a 36-hour exposure to interleukin-1beta.
    Scarim AL; Heitmeier MR; Corbett JA
    Endocrinology; 1997 Dec; 138(12):5301-7. PubMed ID: 9389514
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interleukin-18 mRNA, but not interleukin-18 receptor mRNA, is constitutively expressed in islet beta-cells and up-regulated by interferon-gamma.
    Hong TP; Andersen NA; Nielsen K; Karlsen AE; Fantuzzi G; Eizirik DL; Dinarello CA; Mandrup-Poulsen T
    Eur Cytokine Netw; 2000 Jun; 11(2):193-205. PubMed ID: 10903798
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Islet defects and insulin resistance in models of obese non-insulin-dependent diabetes.
    Bailey CJ; Flatt PR
    Diabetes Metab Rev; 1993 Nov; 9 Suppl 1():43S-50S. PubMed ID: 8299488
    [No Abstract]   [Full Text] [Related]  

  • 55. Inflammatory mediators expressed in human islets of Langerhans: implications for islet transplantation.
    Johansson U; Olsson A; Gabrielsson S; Nilsson B; Korsgren O
    Biochem Biophys Res Commun; 2003 Aug; 308(3):474-9. PubMed ID: 12914774
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cyclosporin depresses pancreatic islet expression of antigens for islet cell autoantibodies in non obese diabetic mice.
    el Mansour A; Martignat L; Maugendre S; Senecat O; Gouin E; Saï P
    J Autoimmun; 1996 Feb; 9(1):29-39. PubMed ID: 8845051
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunoexpression of interleukin-1beta in pancreatic islets of NOD mice during cyclophosphamide-accelerated diabetes: co-localization in macrophages and endocrine cells and its attenuation with oral nicotinamide.
    Reddy S; Young M; Ginn S
    Histochem J; 2001 Jun; 33(6):317-27. PubMed ID: 11758808
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Brain death significantly reduces isolated pancreatic islet yields and functionality in vitro and in vivo after transplantation in rats.
    Contreras JL; Eckstein C; Smyth CA; Sellers MT; Vilatoba M; Bilbao G; Rahemtulla FG; Young CJ; Thompson JA; Chaudry IH; Eckhoff DE
    Diabetes; 2003 Dec; 52(12):2935-42. PubMed ID: 14633854
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Innate immune activation in obesity.
    Lumeng CN
    Mol Aspects Med; 2013 Feb; 34(1):12-29. PubMed ID: 23068074
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Protective effect of adipocytes fatty acid binding protein inhibitor on pancreas islet cell against macrophage-mediated cytotoxicity of mice in vitro].
    Liu SP; He LN; Xiao Y; Li XY; Zhou ZG
    Zhonghua Yi Xue Za Zhi; 2012 Dec; 92(46):3300-4. PubMed ID: 23328519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.